ethyl 4-hydroxy-2-methylthiophene-3-carboxylate, 250mg

1-Ethylimidazolidin-2-one, 95+%, 1g

5-Bromo-6-chloro-N-(2,4-dimethoxybenzyl)-N-(5-fluorothiazol-2-yl)pyridine-3-sulfonamide, 97%, 25mg

1,4-Anthraquinone>93.0%(GC)5g

alpha-D-Mannose pentaacetate, 98.0%, 100g

LuciPac® Pen, 100 pièces

[3-(3,5-dimethyl-1H-pyrazol-1-yl)phenyl]boronic acid, 95.0%, 100mg

1-(Piperidin-4-yl)azetidin-2-one hydrochloride, 97%, 100mg

[S(R)]-N-[(R)-[6-(Diphenylphosphino)benzo[d][1,3]dioxol-5-yl]-1-naphthalenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%, 25mg

3-(tert-Butylamino)propionitrile, 99.0%, 100g

Acide L(+)-tartrique, min 99,5%, Ph.Eur., 5 kg, emballage plastique.

1-Benzyl-4,6-dimethylpiperidin-3-amine dihydrochloride, 97.0%, 1g

Cyclooctanamine, 95.0%, 25ml